Please enable JavaScript to continue using this application.

Compare $ACET vs $ANVS | Chartloom

Compare

$ACET vs $ANVS

Adicet Bio Inc · Annovis Bio Inc

ACET

Adicet Bio Inc

ANVS

Annovis Bio Inc

Compare $ACET vs $ANVS

Comparing Adicet Bio Inc and Annovis Bio Inc

ACETAdicet Bio Inc

ANVSAnnovis Bio Inc

ACETAdicet Bio Inc

Market cap

$52M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-62.2%

FCF yield

-162.0%

ANVSAnnovis Bio Inc

Market cap

$42M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.8%

52W performance

-46.7%

FCF yield

-103.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACET

ANVS

Detailed metrics comparison

ACET

Adicet Bio Inc

ANVS

Annovis Bio Inc

Market Cap

ACET$52M

ANVS$42M

Enterprise Value

ACET$20M

ANVS$23M

Price

ACET$5.61

ANVS$1.21

P/E Ratio

ACETN/A

ANVSN/A

P/S Ratio

ACET1.57x

ANVS0.00x

EV/Sales

ACET0.74x

ANVS0.00x

EV/EBITDA

ACET0.00x

ANVS0.00x

P/B Ratio

ACET0.51x

ANVS16.11x

P/FCF Ratio

ACETN/A

ANVSN/A

EV/FCF

ACET-0.24x

ANVS-0.54x

PEG Ratio

ACETN/A

ANVSN/A

Forward P/E (NTM)

ACETN/A

ANVSN/A

Forward P/S (NTM)

ACETN/A

ANVSN/A

Revenue (TTM)

ACET$0

ANVS$0

Revenue Growth (YoY)

ACETN/A

ANVSN/A

Forward Rev Growth

ACET171.3%

ANVS507.4%

Gross Margin (TTM)

ACET0.0%

ANVS0.0%

Operating Margin (TTM)

ACET0.0%

ANVS0.0%

EBITDA Margin (TTM)

ACET0.0%

ANVS0.0%

Net Margin (TTM)

ACET0.0%

ANVS0.0%

FCF Margin (TTM)

ACETN/A

ANVSN/A

Net Income (TTM)

ACET$-99M

ANVS$-50M

FCF (TTM)

ACET$-85M

ANVS$-43M

EPS (TTM)

ACET-$9.21

ANVS-$1.32

ROE (TTM)

ACET-7490.0%

ANVS-31808.0%

ROA (TTM)

ACET-6087.0%

ANVS-25878.0%

ROIC (TTM)

ACET-7437.0%

ANVS-31808.0%

Cash

ACET$33M

ANVS$19M

Debt

ACET$798K

ANVS$0

Net Cash/Debt

ACET$32M

ANVS$19M

Current Ratio (TTM)

ACET6.71x

ANVS3.47x

Quick Ratio (TTM)

ACET6.59x

ANVS2.95x

Debt/Equity (TTM)

ACET0.01x

ANVS0.00x

Debt/Assets (TTM)

ACET0.0%

ANVS0.0%

Interest Coverage (TTM)

ACETN/A

ANVSN/A

Net Debt/EBITDA (TTM)

ACET0.00x

ANVS0.00x

Beta

ACET1.68

ANVS1.32

52W Performance

ACET-62.2%

ANVS-46.7%

YTD Performance

ACET-36.4%

ANVS-66.8%

% from 52W High

ACET-67.8%

ANVS-78.0%

% from 52W Low

ACET1.1%

ANVS16.3%

Asset Turnover (TTM)

ACET0.13x

ANVS0.00x

FCF Yield (TTM)

ACET-162.0%

ANVS-103.4%

Earnings Yield (TTM)

ACET-188.7%

ANVS-118.1%

Dividend Yield (TTM)

ACETN/A

ANVSN/A

Rule of 40

ACET0.0

ANVS0.0

EV/GP/RG

ACETN/A

ANVSN/A

Ticker research

View ACET research View ANVS research

Metric	ACET Adicet Bio Inc	ANVS Annovis Bio Inc
Market & Valuation
Market Cap	$52M	$42M
Enterprise Value	$20M	$23M
Price	$5.61	$1.21
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	0.00x
EV/Sales	0.74x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	16.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-0.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	507.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-50M
FCF (TTM)	$-85M	$-43M
EPS (TTM)	-$9.21	-$1.32
ROE (TTM)	-7490.0%	-31808.0%
ROA (TTM)	-6087.0%	-25878.0%
ROIC (TTM)	-7437.0%	-31808.0%
Financial Health
Cash	$33M	$19M
Debt	$798K	$0
Net Cash/Debt	$32M	$19M
Current Ratio (TTM)	6.71x	3.47x
Quick Ratio (TTM)	6.59x	2.95x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.32
52W Performance	-62.2%	-46.7%
YTD Performance	-36.4%	-66.8%
% from 52W High	-67.8%	-78.0%
% from 52W Low	1.1%	16.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-103.4%
Earnings Yield (TTM)	-188.7%	-118.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View ANVS research

Valuation

P/S Ratio

ANVS

0.00x

ACET

1.57x

EV/FCF

ANVS

-0.54x

ACET

-0.24x

Growth & revenue

Forward Revenue Growth

ANVS

507.4%

ACET

171.3%

Profitability & performance

Gross Margin

ACET

0.0%

ANVS

0.0%

ROE

ACET

-7490.0%

ANVS

-31808.0%

FCF Yield %

ANVS

-103.4%

ACET

-162.0%

52-Week Performance

ANVS

-46.7%

ACET

-62.2%

Detailed metrics comparison

ACET

Adicet Bio Inc

ANVS

Annovis Bio Inc

Market Cap

ACET$52M

ANVS$42M

Enterprise Value

ACET$20M

ANVS$23M

Price

ACET$5.61

ANVS$1.21

P/E Ratio

ACETN/A

ANVSN/A

P/S Ratio

ACET1.57x

ANVS0.00x

EV/Sales

ACET0.74x

ANVS0.00x

EV/EBITDA

ACET0.00x

ANVS0.00x

P/B Ratio

ACET0.51x

ANVS16.11x

P/FCF Ratio

ACETN/A

ANVSN/A

EV/FCF

ACET-0.24x

ANVS-0.54x

PEG Ratio

ACETN/A

ANVSN/A

Forward P/E (NTM)

ACETN/A

ANVSN/A

Forward P/S (NTM)

ACETN/A

ANVSN/A

Revenue (TTM)

ACET$0

ANVS$0

Revenue Growth (YoY)

ACETN/A

ANVSN/A

Forward Rev Growth

ACET171.3%

ANVS507.4%

Gross Margin (TTM)

ACET0.0%

ANVS0.0%

Operating Margin (TTM)

ACET0.0%

ANVS0.0%

EBITDA Margin (TTM)

ACET0.0%

ANVS0.0%

Net Margin (TTM)

ACET0.0%

ANVS0.0%

FCF Margin (TTM)

ACETN/A

ANVSN/A

Net Income (TTM)

ACET$-99M

ANVS$-50M

FCF (TTM)

ACET$-85M

ANVS$-43M

EPS (TTM)

ACET-$9.21

ANVS-$1.32

ROE (TTM)

ACET-7490.0%

ANVS-31808.0%

ROA (TTM)

ACET-6087.0%

ANVS-25878.0%

ROIC (TTM)

ACET-7437.0%

ANVS-31808.0%

Cash

ACET$33M

ANVS$19M

Debt

ACET$798K

ANVS$0

Net Cash/Debt

ACET$32M

ANVS$19M

Current Ratio (TTM)

ACET6.71x

ANVS3.47x

Quick Ratio (TTM)

ACET6.59x

ANVS2.95x

Debt/Equity (TTM)

ACET0.01x

ANVS0.00x

Debt/Assets (TTM)

ACET0.0%

ANVS0.0%

Interest Coverage (TTM)

ACETN/A

ANVSN/A

Net Debt/EBITDA (TTM)

ACET0.00x

ANVS0.00x

Beta

ACET1.68

ANVS1.32

52W Performance

ACET-62.2%

ANVS-46.7%

YTD Performance

ACET-36.4%

ANVS-66.8%

% from 52W High

ACET-67.8%

ANVS-78.0%

% from 52W Low

ACET1.1%

ANVS16.3%

Asset Turnover (TTM)

ACET0.13x

ANVS0.00x

FCF Yield (TTM)

ACET-162.0%

ANVS-103.4%

Earnings Yield (TTM)

ACET-188.7%

ANVS-118.1%

Dividend Yield (TTM)

ACETN/A

ANVSN/A

Rule of 40

ACET0.0

ANVS0.0

EV/GP/RG

ACETN/A

ANVSN/A

Ticker research

View ACET research View ANVS research

Metric	ACET Adicet Bio Inc	ANVS Annovis Bio Inc
Market & Valuation
Market Cap	$52M	$42M
Enterprise Value	$20M	$23M
Price	$5.61	$1.21
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	0.00x
EV/Sales	0.74x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	16.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-0.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	507.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-50M
FCF (TTM)	$-85M	$-43M
EPS (TTM)	-$9.21	-$1.32
ROE (TTM)	-7490.0%	-31808.0%
ROA (TTM)	-6087.0%	-25878.0%
ROIC (TTM)	-7437.0%	-31808.0%
Financial Health
Cash	$33M	$19M
Debt	$798K	$0
Net Cash/Debt	$32M	$19M
Current Ratio (TTM)	6.71x	3.47x
Quick Ratio (TTM)	6.59x	2.95x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.32
52W Performance	-62.2%	-46.7%
YTD Performance	-36.4%	-66.8%
% from 52W High	-67.8%	-78.0%
% from 52W Low	1.1%	16.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-103.4%
Earnings Yield (TTM)	-188.7%	-118.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View ANVS research